Literature DB >> 11695988

Identification of an octamer element required for in vivo expression of the TIE1 gene in endothelial cells.

S C Boutet1, T Quertermous, B M Fadel.   

Abstract

TIE1, an endothelial-cell-specific tyrosine kinase receptor, is required for the survival and growth of microvascular endothelial cells during the capillary sprouting phase of vascular development. To investigate the molecular mechanisms that regulate the expression of TIE1 in the endothelium, we analysed transgenic mouse embryos carrying wild-type or mutant TIE1 promoter/LacZ constructs. Our data indicate that an upstream DNA octamer element (5'-ATGCAAAT-3') is required for the in vivo expression of TIE1 in embryonic endothelial cells. Transgenic embryos carrying the wild-type TIE1 promoter (-466 to +78 bp) fused to LacZ and spanning the octamer element demonstrate endothelial-cell-specific expression of the reporter transgene. Point mutations introduced within the octamer element result in a significant decrease of endothelial LacZ expression, suggesting that the octamer site functions as a positive regulator for TIE1 gene expression in endothelial cells. DNA-protein binding studies show that the octamer element exhibits an endothelial-cell-specific pattern of binding via interaction with endothelial-cell-restricted factor(s). Our findings suggest an important role for the octamer element in regulating the expression of the TIE1 receptor in the embryonic endothelium and suggest a common mechanism for the regulation of the angiogenic and cell-specific TIE1 and TIE2 genes during vascular development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11695988      PMCID: PMC1222198          DOI: 10.1042/0264-6021:3600023

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.

Authors:  T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

2.  Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B.

Authors:  Y Luo; R G Roeder
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

3.  A B-cell coactivator of octamer-binding transcription factors.

Authors:  M Gstaiger; L Knoepfel; O Georgiev; W Schaffner; C M Hovens
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

4.  Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

Authors:  C Suri; P F Jones; S Patan; S Bartunkova; P C Maisonpierre; S Davis; T N Sato; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

5.  Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development.

Authors:  D J Dumont; G H Fong; M C Puri; G Gradwohl; K Alitalo; M L Breitman
Journal:  Dev Dyn       Date:  1995-05       Impact factor: 3.780

6.  OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins.

Authors:  M Strubin; J W Newell; P Matthias
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

7.  Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice.

Authors:  T M Schlaeger; S Bartunkova; J A Lawitts; G Teichmann; W Risau; U Deutsch; T N Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  Endothelial-specific gene expression directed by the tie gene promoter in vivo.

Authors:  J Korhonen; I Lahtinen; M Halmekytö; L Alhonen; J Jänne; D Dumont; K Alitalo
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

9.  Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development.

Authors:  J Partanen; M C Puri; L Schwartz; K D Fischer; A Bernstein; J Rossant
Journal:  Development       Date:  1996-10       Impact factor: 6.868

10.  The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.

Authors:  M C Puri; J Rossant; K Alitalo; A Bernstein; J Partanen
Journal:  EMBO J       Date:  1995-12-01       Impact factor: 11.598

View more
  5 in total

1.  A multi-gene transcriptional profiling approach to the discovery of cell signature markers.

Authors:  Youichiro Wada; Dan Li; Anne Merley; Andrew Zukauskas; William C Aird; Harold F Dvorak; Shou-Ching Shih
Journal:  Cytotechnology       Date:  2010-10-23       Impact factor: 2.058

2.  Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

Authors:  Susanna Camós; Carme Gubern; Mónica Sobrado; Rocío Rodríguez; Víctor G Romera; María Ángeles Moro; Ignacio Lizasoain; Joaquín Serena; Judith Mallolas; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2013-11-27       Impact factor: 3.843

3.  Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Tara Schmidt; Jianzhu Chen; Phillip A Sharp; Dean Tantin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

4.  Comprehensive transcriptome mining of the direct conversion of mesodermal cells.

Authors:  Bijan Akbari; Ping Wee; Moein Yaqubi; Abdulshakour Mohammadnia
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

5.  Temporal and Spatial Post-Transcriptional Regulation of Zebrafish tie1 mRNA by Long Noncoding RNA During Brain Vascular Assembly.

Authors:  Tamjid A Chowdhury; Chris Koceja; Shahram Eisa-Beygi; Benjamin P Kleinstiver; Suresh N Kumar; Chien-Wei Lin; Keguo Li; Shubhangi Prabhudesai; J Keith Joung; Ramani Ramchandran
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-03       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.